{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-205350","form_type":"8-K","ticker":"FBRX","cik":"0001419041","company_name":"Forte Biosciences, Inc.","filed_at":"2024-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.991382+00:00","generated_at":"2026-05-31T08:02:40.894121+00:00","sec_items":["5.02","5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Forte Biosciences secures shareholder approval for 1-for-25 reverse split effective Aug 28","bullets":["Reverse stock split ratio set at 1-for-25; effective Aug 28, 2024, with new CUSIP 34962G 208.","Stockholders approved amendment to effect reverse split (26.7M for, 2.1M against).","Amended 2021 Equity Incentive Plan approved (17.3M for, 6.9M against); adds up to 8.5M new shares plus up to 1.1M from prior plans.","Class I directors elected: Barbara K. Finck, M.D. (18.8M for), Donald A. Williams (15.4M for), Stephen K. Doberstein (15.1M for).","KPMG LLP ratified as independent auditor for FY2024 with 28.8M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-205350","json":"https://secwatch.observer/filing/0001193125-24-205350.json","markdown":"https://secwatch.observer/filing/0001193125-24-205350.md","text":"https://secwatch.observer/filing/0001193125-24-205350.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419041/000119312524205350/0001193125-24-205350-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419041/000119312524205350/d888554d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:02:40.894121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}